COYA - CIK 0001835022
Coya Therapeutics, Inc. (COYA) reported revenue of $7.95M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $7.95M | +123.6% |
| FY 2024 | $3.55M | -40.8% |
| FY 2023 | $6.00M | - |
| FY 2022 | $0.00 | - |
Coya Therapeutics, Inc. (COYA) reported revenue of $7.95M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.